Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: Protocol

BACKGROUND: Warfarin and similar vitamin K antagonists have been the standard therapy for patients with mechanical or biological valve prosthesis and atrial fibrillation (AF). Even with the appropriate use of therapy, some studies have reported that there is a high incidence of thromboembolic events...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Duraes, Andre Rodrigues, Roriz, Pollianna DS, Bulhoes, Fabio V, Nunes, Bianca DA, Muniz, Juliana QV, Neto, Italvar NDCR, Fernandes, Andre MS, Reis, Francisco JFBD, Camara, Edmundo JN, Junior, Erenaldo DSR, Segundo, Deusdeth TS, Silva, Felipe Pinho E Albuquerque, Aras, Roque
Format: Artigo
Idioma:Inglês
Publicat: JMIR Publications Inc. 2014
Matèries:
Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4004148/
https://ncbi.nlm.nih.gov/pubmed/24691436
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2196/resprot.3014
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars